Klaviyo Inc
NYSE:KVYO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
21.53
44.08
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
KVYO Price Targets Summary
Klaviyo Inc
According to Wall Street analysts, the average 1-year price target for KVYO is 42.69 USD with a low forecast of 35.35 USD and a high forecast of 49.35 USD.
KVYO Last Price Targets
Klaviyo Inc
The latest public price target was made on Nov 7, 2024 by Scott Berg from Needham , who expects KVYO stock to rise by 4% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
Analyst | Price Target | Date | Article |
---|---|---|---|
Scott Berg
Needham
|
46
USD
Upside 4% |
1 month ago
Nov 7, 2024
|
Klaviyo Inc (KVYO) PT Raised to $46 at Needham
StreetInsider
|
Ross Compton
Macquarie
|
36
USD
Downside 18% |
1 month ago
Oct 31, 2024
|
Klaviyo initiated with a Neutral at Macquarie
TheFly
|
Parker Lane
Stifel Nicolaus
|
45
USD
Upside 2% |
2 months ago
Oct 21, 2024
|
Klaviyo initiated with a Buy at Stifel
TheFly
|
Brent Bracelin
Piper Sandler
|
45
USD
Upside 2% |
2 months ago
Oct 18, 2024
|
Klaviyo price target raised to $45 from $34 at Piper Sandler
TheFly
|
Raimo Lenschow
Barclays
|
41
USD
Downside 7% |
2 months ago
Oct 11, 2024
|
Klaviyo price target raised to $41 from $32 at Barclays
TheFly
|
Rob Oliver
Robert W. Baird
|
42
USD
Downside 5% |
2 months ago
Oct 10, 2024
|
Klaviyo price target raised to $42 from $35 at Baird
TheFly
|
Brent Bracelin
Piper Sandler
|
34
USD
Downside 23% |
4 months ago
Aug 8, 2024
|
Klaviyo price target raised to $34 from $30 at Piper Sandler
TheFly
|
Jackson Ader
KeyBanc
|
33
USD
Downside 25% |
4 months ago
Aug 8, 2024
|
KeyBanc Upgrades Klaviyo Inc (KVYO) to Overweight
StreetInsider
|
Raimo Lenschow
Barclays
|
29
USD
Downside 34% |
6 months ago
Jun 12, 2024
|
Barclays Upgrades Klaviyo Inc (KVYO) to Overweight
StreetInsider
|
Siti Panigrahi
Mizuho Securities
|
35
USD
Downside 21% |
7 months ago
May 9, 2024
|
Klaviyo Inc (KVYO) PT Lowered to $35 at Mizuho
StreetInsider
|
Rob Oliver
Robert W. Baird
|
35
USD
Downside 21% |
7 months ago
May 9, 2024
|
Klaviyo Inc (KVYO) PT Lowered to $35 at Baird
StreetInsider
|
Brett Knoblauch
Cantor Fitzgerald
|
31
USD
Downside 30% |
8 months ago
Apr 16, 2024
|
Cantor Fitzgerald Starts Klaviyo Inc (KVYO) at Overweight
StreetInsider
|
Shebly Seyrafi
FBN Securities
|
35
USD
Downside 21% |
9 months ago
Mar 20, 2024
|
FBN Securities Starts Klaviyo Inc (KVYO) at Outperform
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is KVYO's stock price target?
Price Target
42.69
USD
According to Wall Street analysts, the average 1-year price target for KVYO is 42.69 USD with a low forecast of 35.35 USD and a high forecast of 49.35 USD.
What is Klaviyo Inc's Revenue forecast?
Projected CAGR
25%
For the last 1 year the compound annual growth rate for Klaviyo Inc's revenue is 48%. The projected CAGR for the next 4 years is 25%.